Lilly S.A.
⚠️ High Risk
FEI: 3000235541 • Alcobendas, Madrid • SPAIN
FEI Number
3000235541
Location
Alcobendas, Madrid
Country
SPAINAddress
Avenida De La Industria 30, , Alcobendas, Madrid, Spain
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
NO ENGLISH
Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 9/3/2025 | 62QCY05BARICITINIB (ANTI-RHEUMATIC) | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 3/20/2024 | 66SCA99VASODILATOR N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2019 | 66SDB51TADALAFIL | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/21/2017 | 66SCG51TADALAFIL | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/7/2016 | 66SAA51TADALAFIL | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/7/2016 | 66SDY99VASODILATOR N.E.C. | Division of Northeast Imports (DNEI) | |
| 9/22/2015 | 61NDY85DULOXETINE HYDROCHLORIDE (ANTI-DEPRESSANT) | 75UNAPPROVED | Division of Northern Border Imports (DNBI) |
| 7/3/2012 | 66NCE02OLANZAPINE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II | New Orleans District Office (NOL-DO) | |
| 5/9/2012 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 3/28/2005 | 64RCP22SOMATROPIN (RDNA ORIGIN) (HORMONE) | New York District Office (NYK-DO) |
Frequently Asked Questions
What is Lilly S.A.'s FDA import refusal history?
Lilly S.A. (FEI: 3000235541) has 10 FDA import refusal record(s) in our database, spanning from 3/28/2005 to 9/3/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Lilly S.A.'s FEI number is 3000235541.
What types of violations has Lilly S.A. received?
Lilly S.A. has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Lilly S.A. come from?
All FDA import refusal data for Lilly S.A. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.